Alpha Crest Capital Management LLC Apellis Pharmaceuticals, Inc. Transaction History

Alpha Crest Capital Management LLC

  • $0
  • Q4 2022

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$35.46 - $54.12 $303,395 - $463,050
-8,556 Closed
0 $0
Q4 2021

Feb 09, 2022
BUY
$30.74 - $49.16 $263,011 - $420,612
8,556 New
8,556 $405,000
Q2 2021

Aug 12, 2021
SELL
$40.9 - $64.9 $756,650 - $1.2 Million
-18,500 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$40.8 - $57.39 $424,319 - $596,856
10,400 Added 128.4%
18,500 $794,000
Q4 2020

Feb 12, 2021
BUY
$30.79 - $57.2 $249,399 - $463,320
8,100 New
8,100 $463,000

Others Institutions Holding APLS

# of Institutions
309
Shares Held
115M
Call Options Held
3.85M
Put Options Held
1.09M
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.05B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Alpha Crest Capital Management LLC Portfolio

Follow Alpha Crest Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email